Geovanni L. Janer Carattini

Geovanni L. Janer Carattini

Auto-generated profile, based on publicly available information

Geovanni L. Janer Carattini

Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2025 in Annual Review of Genomics and Human Genetics
Verified
Journal Article
Open access
ATAbby R. Thurm
Abby R. Thurm
GCGeovanni L. Janer Carattini
Geovanni L. Janer Carattini
LBLacramioara Bintu
Lacramioara Bintu
The growing field of human synthetic biology has rapidly accelerated the development of programmable genetic systems that can control cellular phenotypes and function. As the scale of synthetic systems has increased, researchers have focused on identifying modular regulators that act at the levels of DNA, RNA, and protein to create synthetic control points at each level of gene expression. Expanding these assays to multiple cellular contexts has made it possible to both manipulate endogenous gene programs and create synthetic gene circuits that yield designer cell outputs. Here, we review recent advances in high-throughput human synthetic biology that have led to the development of multilevel tools for gene expression control. We highlight the development of synthetic gene programs that can both provide information on and manipulate cellular behavior and discuss the application of programmable genetic tools in therapeutic contexts to illuminate the power of these new biological approaches.

26 January 2024 in Science Advances
Verified
Journal Article
Open access
NSNicholas Strash
Nicholas Strash
SDSophia DeLuca
Sophia DeLuca
GCGeovanni L. Janer Carattini
Geovanni L. Janer Carattini
YCYifan Chen
Yifan Chen
TWTianyu Wu
Tianyu Wu
NBNenad Bursac
Nenad Bursac
Candidate cardiomyocyte (CM) mitogens such as those affecting the extracellular signal–regulated kinase (ERK) signaling pathway represent potential targets for functional heart regeneration. We explored whether activating ERK via a constitutively active mutant of B-raf proto-oncogene (BRAF), BRAF-V600E (caBRAF), can induce proproliferative effects in neonatal rat engineered cardiac tissues (ECTs). Sustained CM-specific caBRAF expression induced chronic ERK activation, substantial tissue growth, deficit in sarcomeres and contractile function, and tissue stiffening, all of which persisted for at least 4 weeks of culture. caBRAF-expressing CMs in ECTs exhibited broad transcriptomic changes, shift to glycolytic metabolism, loss of connexin-43, and a promigratory phenotype. Transient, doxycycline-controlled caBRAF expression revealed that the induction of CM cycling is rapid and precedes functional decline, and the effects are reversible only with short-lived ERK activation. Together, direct activation of the BRAF kinase is sufficient to modulate CM cycling and functional phenotype, offering mechanistic insights into roles of ERK signaling in the context of cardiac development and regeneration.

12 December 2025 in bioRxiv
Verified
Preprint
Open access
CACecelia J Andrews
Cecelia J Andrews
ECEli J Costa
Eli J Costa
GCGeovanni L Janer Carattini
Geovanni L Janer Carattini
NDNicole V DelRosso
Nicole V DelRosso
TFTaihei Fujimori
Taihei Fujimori
LBLacramioara Bintu
Lacramioara Bintu
Dynamic gene expression pulses enable adaptive response to stimuli and can be generated in natural and synthetic systems. Controlling these dynamics typically involves circuits consisting of multiple genes and transcription factors (TFs). Here, we discover a new class of bifunctional transcriptional effector domains that can first activate and subsequently repress the same gene, producing dynamic gene expression pulses from a single input. These pulse dynamics arise from distinct, temporally separated chromatin states defined by active and repressive chromatin modifications. The balance between active and repressed states is determined by the DNA occupancy of the bifunctional TF. Bifunctional domains activate at low occupancy but switch to repression at high occupancy, resulting in a non-monotonic TF input-gene expression output relationship tunable by TF concentration and number of DNA binding sites. We develop a kinetic model that links TF occupancy to gene expression transitions, allowing for the programming of eight distinct cell "states" - combinations of On/Off states of 3 reporter genes - using a single bifunctional effector. This work establishes the theoretical framework and molecular mechanisms of pulse-generating gene regulation by bifunctional domains and creates a foundation for engineering complex multi-gene circuits.

1 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNicholas Strash
Nicholas Strash
SDSophia DeLuca
Sophia DeLuca
GCGeovanni L. Janer Carattini
Geovanni L. Janer Carattini
YCYifan Chen
Yifan Chen
JSJacob Scherba
Jacob Scherba
NBNenad Bursac
Nenad Bursac
Mitogens capable of promoting cardiomyocyte proliferation represent important targets for functional heart regeneration following myocardial infarction. We previously described an ERK-dependent pro-proliferative tissue phenotype following overexpression of constitutively-active (ca) human ERBB2 in both neonatal rat ventricular myocytes (NRVMs) and human iPSC-derived cardiomyocytes (hiPSC-CMs). Since ERBB2 canonically regulates multiple other pathways in addition to ERK, it is unclear whether ERK activation alone can drive CM proliferation. Here, we activated ERK in a targeted fashion by CM-specific lentiviral expression of a constitutively active mutant of BRAF, BRAF-V600E (caBRAF), in cultured NRVMs and examined the effects on engineered NRVM tissue proliferation, morphology, and function. caBRAF expression induced ERK activation, tissue growth, loss of contractile function, and increased tissue stiffness, all of which were sustained for at least 4 weeks in vitro . From bulk RNA-sequencing analysis of engineered tissues, we found that caBRAF had broad transcriptomic effects on CMs and induced a shift to glycolytic metabolism. Together, this work shows that direct ERK activation is sufficient to modulate CM cycling and functional maturation in a cell-autonomous fashion and could offer a potential target for cardiac regenerative therapies.

15 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
NSNicholas Strash
Nicholas Strash
SDSophia DeLuca
Sophia DeLuca
GCGeovanni L. Janer Carattini
Geovanni L. Janer Carattini
SHSoon Chul Heo
Soon Chul Heo
RGRyne Gorsuch
Ryne Gorsuch
NBNenad Bursac
Nenad Bursac
Multiple mitogenic pathways capable of promoting mammalian cardiomyocyte (CM) proliferation have been identified as potential candidates for functional heart repair following myocardial infarction. However, it is unclear whether the effects of these mitogens are species-specific and how they directly compare in the same cardiac setting. Here, we examined how CM-specific lentiviral expression of various candidate mitogens affects human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and neonatal rat ventricular myocytes (NRVMs) in vitro . In 2D-cultured CMs from both species, and in highly mature 3D-engineered cardiac tissues generated from NRVMs, a constitutively-active mutant form of the human gene Erbb2 (cahErbb2) was the most potent tested mitogen. Persistent expression of cahErbb2 induced CM proliferation, sarcomere loss, and remodeling of tissue structure and function, which were attenuated by small molecule inhibitors of Erk signaling. These results suggest transient activation of Erbb2/Erk axis in cardiomyocytes as a potential strategy for regenerative heart repair.